To stop the progress of antimicrobial resistance today means to give a chance of mankind surviving tomorrow | CMAC

To stop the progress of antimicrobial resistance today means to give a chance of mankind surviving tomorrow

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):310-315

​ Kozlov R.S., Golub A.V.
10.36488/cmac.2019.4.310-315
antimicrobials antimicrobial resistance human infections microorganisms pathogens
Section
Antimicrobials
Type
Review
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):310-315

Abstract

Antimicrobial resistance is a global challenge for human society. Scientists around the world are trying not to return to the time when antimicrobials were not yet discovered, and millions of people were dying from infections. This article describes the current state of the antimicrobial resistance problem in Russia as well as the ways to solve it.

Roman S. Kozlov

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

Alexey V. Golub

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

  • 1. Wilcox M.H. The tide of antimicrobial resistance and selection. Int J Antimicrob Agents. 2009;34(Suppl. 3):S6-10. DOI: 10.1016/S0924-8579(09)70550-3
  • 2. Jones R.N. Resistance patterns among nosocomial pathogens. Trends over the past few years. Chest. 2001;119(Suppl. 2):397S-404S. DOI: 10.1378/chest.119.2_suppl.397s
  • 3. Safdar N., Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant S. aureus, Enterococcus, gram-negative bacilli, C. difficile and Candida. Ann Intern Med. 2002;136(11):834-844. DOI: 10.7326/0003-4819-136-11-200206040-00013
  • 4. Kozlov R.S. Selection of resistance associated with the use of antimicrobial agents: collateral damage concept. Clinical microbiology and antimicrobial chemotherapy. 2010;12(14):284294. Russian.
  • 5. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A., Hujer A.M., et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in stool of colonized patients. N Engl J Med. 2000;343:1925-1932. DOI: 10.1056/NEJM200012283432604
  • 6. Tackling drug-resistant infections globally: final report and recommendations. Available at: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf.
  • 7. Kozlov R.S. Pneumococci: lessons of the past – a look into the future. Smolensk: IACMAC; 2010. Russian.
  • 8. Estes K. Methicillin-Resistant Staphylococcus aureus skin and soft tissue infections. Crit Care Nurs Q. 2011;34(2):101-109. DOI: 10.1097/CNQ.0b013e31820f6f9e
  • 9. Tracy L.A., Furuno J.P., Harris A.D., Singer M., Langenberg P., Roghmann M.C. Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008. Emerg Infect Dis. 2011;17(3):441448. DOI: 10.3201/eid1703.100502
  • 10. Paterson D.L., Rossi F., Baquero F., Hsueh P.R., Woods G.L., Satishchandran V., et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patient with intraabdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trend (SMART). J Antimicrob Chemother. 2005;55(6):965-973. DOI: 10.1093/jac/dki117
  • 11. Kuzmenkov A.Yu, Trushin I.V, Avramenko A.A., Edelstein M.V., Dekhnich A.V., Kozlov R.S. AMRmap: an online platform for monitoring antibiotic resistance. Clinical microbiology and antimicrobial chemotherapy. 2017;19(2):84-90. Russian.
  • 12. Call for participation: Global Antimicrobial Resistance Surveillance System (GLASS). Available at: https://www.who.int/drugresistance/surveillance/glass-enrolment/en/. Russian.
  • 13. Golding S.E., Ogden J., Higgins H.M. Shared goals, different barriers: a qualitative study of UK veterinarians and farmers beliefs about antimicrobial resistance and stewardship. Front Vet Sci. 2019;6:132. DOI: 10.3389/fvets.2019.00132
  • 14. Dellit T.H., Owens R.C., McGowan J.E, Gerding D.N., Weinstein R.A., Burke J.P., et al. Infectious diseases society of America and the Society for healthcare epidemiology of America Guidelines for developing an Institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. DOI: 10.1086/510393
  • 15. Kish M.A. Guide to development of practice guidelines. Clin Infect Dis. 2001;32(6):851-854. DOI: 10.1086/319366
  • 16. Goldman D.A., Weinstein R.A., Wenzel R.P., Tablan O.C., Duma R.J., Gaynes R.P., et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA. 1996;275(3):234-240.
  • 17. Rahal J.J., Urban C., Horn D., Freeman K., Segal-Maurer S., Maurer J., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233-1237. DOI: 10.1001/jama.280.14.1233
  • 18. Quale J., Landman D., Saurina G., Atwood E., DiTore V., Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis. 1996;23(5):1020-1025. DOI: 10.1093/clinids/23.5.1020
  • 19. Charbonneau P., Parienti J., Thibon P., Ramakers M., Daubin C., du Cheyron D., et al. Fluoroquinilone use and methicillinresistant S. aureus isolation rates in hospitalized patient: a quasi experimental study. Clin Infect Dis. 2006;42(6):778-784. DOI: 10.1086/500319
  • 20. Chastre J., Wolff M., Fagon J.Y., Chevret S., Thomas F., Wermert D., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290(19):2588-2598. DOI: 10.1001/jama.290.19.2588
  • 21. Singh N., Rogers P., Atwood C.W., Wagener M.M., Yu V.L. Short-course empiric antibiotic therapy for patient with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162(2 Pt. 1):505-511. DOI: 10.1164/ajrccm.162.2.9909095
  • 22. Dennesen P.J., van der Ven A.J., Kessels A.G., Ramsay G., Bonten M.J. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163(6):1371-1375. DOI: 10.1164/ajrccm.163.6.2007020
  • 23. Luna C.M., Blanzaco D., Niederman M.S., Matarucco W., Baredes N.C., Desmery P., et al. Resolution of ventilatorassociated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31(3):676-682. DOI: 10.1097/01.CCM.0000055380.86458.1E
  • 24. Combes A., Figliolini C., Trouillet J.L., Kassis N., Dombret M.C., Wolff M., et al. Factors predicting ventilator-associated pneumonia recurrence. Crit Care Med. 2003;31(4):1102-1107. DOI: 10.1097/01.CCM.0000059313.31477.2C
  • 25. Paterson D.L. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis. 2006;42(Suppl. 2):90-95. DOI: 10.1086/499407
  • 26. Livermore D.M. Minimising antibiotic resistance. Lancet Infect Dis. 2005;5(7):450-459. DOI: 10.1016/S1473-3099(05)70166-3
  • 27. Kollef M.H., Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134(4):298-314. DOI: 10.7326/0003-4819-134-4-200102200-00014
  • 28. Struelens M.J., Byl B., Vincent J.L. Antibiotic policy: a tool for controlling resistance of hospital pathogens. Clin Microbiol Infect. 1999;5(Suppl. 1):S19-S24. DOI: 10.1111/j.14690691.1999.tb00720.x
  • 29. McGowan J.E. Antimicrobial resistance in hospital organisms and its relations to antibiotic use. Rev Infect Dis. 1983;5(6):10331048. DOI: 10.1093/clinids/5.6.1033
  • 30. Chastre J., Luyt C., Combes A., Trouillet J.L. Use of quantitative cultures and reduced duration of antibiotic regimen for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit. Clin Infect Dis. 2006;43(Suppl. 2):75-81. DOI: 10.1086/504483
  • 31. Dryden M., Hand K., Davey P. Antibiotics for community-acquired pneumonia. J Antimicrob Chemother. 2009;64(6):1123-1125. DOI: 10.1093/jac/dkp359
  • 32. Proud A., Saeed K., Dryden M.S. Serum procalcitonin as guide to antibiotic management. Proceedings of Federation of Infection Societies Conference. Birmingham, UK: 2009. Poster 0135.
  • 33. Available at: www.antibiotic-save.ru.
  • 34. Kozlov R.S., Golub A.V. Antimicrobial stewardship as a renascence of the “Golden age” of antibiotics. Clinical microbiology and antimicrobial chemotherapy. 2011;13(4):322-334. Russian.
  • 35. The strategy and tactics of the use of antimicrobial agents in medical institutions of Russia. Russian national recommendations. Eds. Savelyev V.S., Gelfand B.R., Yakovlev S.V. M.: Borges, 2012. 95 p. Russian.
  • 36. Abdominal surgical infection: Russian national guidelines. Eds. Gelfand B.R., Kirienko A.I., Khachatryan N.N. M.: OOO «Medicinskoe informacionnoe agentstvo», 2018. 168 p. Russian.
  • 37. Available at: www.garant.ru/products/ipo/prime/doc/71677266/.
  • 38. Available at: www.iacmac.ru/.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared